Rebleeding in cerebral amyloid angiopathy

Cerebral amyloid angiopathy (CAA) leads to considerable morbidity and mortality through recurrent lobar intracerebral hemorrhages (ICH). In clinical practice, it is a challenge to identify patients at high risk for a recurrence because of limited clinical and neuroimaging predictors for rebleeding.